Ligand Bias of Scoring Functions in Structure-Based Virtual Screening-Reference-Cited by-同舟云学术

Ligand Bias of Scoring Functions in Structure-Based Virtual Screening

Published:2006-01-04 Issue:3 Volume:46 Page:1334-1343
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Jacobsson Micael¹,Karlén Anders¹

Affiliation:

1. Department of Medicinal Chemistry, Faculty of Pharmacy, University of Uppsala, Box 574, SE-751 23 Uppsala, Sweden, and Department of Chemistry, Biovitrum AB, SE-112 76 Stockholm, Sweden

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci050407t

Reference57 articles.

1. Docking and Database Screening Reveal New Classes of Plasmodium falciparum Dihydrofolate Reductase Inhibitors

2. Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B

3. Optimization and Validation of a Docking-Scoring Protocol; Application to Virtual Screening for COX-2 Inhibitors

4. Docking and scoring in virtual screening for drug discovery: methods and applications

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Docking-Based Virtual Screening Method for Selecting Natural Compounds with Synergistic Inhibitory Effects Against Cancer Signalling Pathways Using a Multi-Target Approach;IRAN J BIOTECHNOL;2024

2. Elucidating the molecular mechanisms of essential oils' insecticidal action using a novel cheminformatics protocol;Scientific Reports;2023-03-21

3. Virtual Screening and Bioactivity Modeling for G Protein‐Coupled Receptors;GPCRs as Therapeutic Targets;2022-09-16

4. Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) ?Cis-On? Agonist;ACS CHEM NEUROSCI;2022

5. Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB₁R) “Cis-On” Agonist;ACS Chemical Neuroscience;2022-07-26